Stroke:儿童局灶性脑动脉病的激素疗法

2017-10-17 杨中华 脑血管病及重症文献导读

大约一半的儿童期动脉缺血性卒中病因为动脉病,其中1/3可能为局灶性脑动脉病(focal cerebral arteriopathy,FCA)。FCA的病程是动态的,开始表现为进展性狭窄,随后很长一段时间内稳定或改善。FCA所致动脉缺血性卒中的临床特征包括先前TIA,波动性症状,大部分累及前循环近端比如MCA M1段和颈动脉远端,皮层下缺血梗死包括基底节梗死。越来越多的人认为FCA是一种炎性动脉


大约一半的儿童期动脉缺血性卒中病因为动脉病,其中1/3可能为局灶性脑动脉病(focal cerebral arteriopathy,FCA)。FCA的病程是动态的,开始表现为进展性狭窄,随后很长一段时间内稳定或改善。FCA所致动脉缺血性卒中的临床特征包括先前TIA,波动性症状,大部分累及前循环近端比如MCA M1段和颈动脉远端,皮层下缺血梗死包括基底节梗死。越来越多的人认为FCA是一种炎性动脉病,最可能为特定儿童感染所致。组织病理学证据很少,但是2项大型观察性研究支持炎性机制。首先,越来越多的证据显示FCA大多发生在近期感染的情况下。其次,血管壁强化也提示了急性炎症过程。

因此,使用皮质醇治疗的儿童FCA所致动脉缺血性卒中也越来越多。然而,目前尚不清楚FCA是否一定是炎性动脉病,假如FCA就是炎性动脉病,它是不是特发性,是不是由病毒感染诱发,或病毒感染后的炎症反应。

为此,2017年9月来自瑞士贝恩大学儿童医院的Maja Steinlin等在Stroke上公布了他们的研究结果,目的在于探讨FCA动脉缺血性卒中儿童增加皮质醇治疗是否能够改善临床预后,降低复发率。

该研究为多中心回顾性瑞士/澳大利亚队列研究,纳入了1个月到18岁的连续患者,推测首次动脉缺血性卒中的病因为FCA。一组患者仅抗栓治疗,另外一组患者抗栓治疗联合皮质醇治疗。主要终点为动脉缺血性卒中后6个月神经功能缺损(Pediatric Stroke Outcome Measure)。

该研究共纳入了73例儿童,21例接受了联合治疗。卒中发病时的平均年龄为7.9岁,联合组和单独抗栓组儿童NIHSS评分平均为3分和5分(P = 0.098)。发病6个月后Pediatric Stroke Outcome Measure平均为0.5和1.0(P = 0.35),调整混淆因素后未变化。联合组和单独抗栓组狭窄完全消失(MRI)的比例分别为81%和59%(P = 0.197)。每组各有一例复发。

最终作者认为对于FCA动脉缺血性卒中儿童,与单独抗栓治疗相比增加皮质醇治疗能够改善神经功能预后。需要大型前瞻性研究证实这个结论。

原始出处:

Steinlin M, Bigi S, Stojanovski B, Gajera J, et al.Focal Cerebral Arteriopathy: Do Steroids Improve Outcome?Stroke. 2017 Sep;48(9):2375-2382. doi: 10.1161/STROKEAHA.117.016818. Epub 2017 Jul 21.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-19 大爰

    学习了谢谢分享!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-19 2227437833_79976374

    很好很好很好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-18 139****0239

    henhao

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-18 2227437833_79976374

    很好很好很好

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1769227, encodeId=52c31e6922763, content=<a href='/topic/show?id=33464e5875e' target=_blank style='color:#2F92EE;'>#局灶性脑动脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47587, encryptionId=33464e5875e, topicName=局灶性脑动脉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e5637990872, createdName=showtest, createdTime=Sun Dec 10 20:16:00 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009678, encodeId=aa8f20096e858, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri Nov 03 05:16:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254347, encodeId=372325434e68, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Oct 19 17:50:09 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531158, encodeId=6024153115878, content=<a href='/topic/show?id=ad8f668407d' target=_blank style='color:#2F92EE;'>#激素疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66840, encryptionId=ad8f668407d, topicName=激素疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=822512217606, createdName=lisa442, createdTime=Thu Oct 19 12:16:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254234, encodeId=f63125423402, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Thu Oct 19 08:09:39 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254083, encodeId=6cd6254083d9, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Wed Oct 18 17:40:33 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253954, encodeId=0948253954df, content=很好很好很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Oct 18 07:54:14 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253804, encodeId=331e25380459, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Tue Oct 17 22:00:52 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-17 1e0e5697m83(暂无匿称)

    henhao

    0

相关资讯

MMWR:研究显示,大部分艾滋病儿童得不到救治,会不会成为新的危机?

近期的一篇在线文章引起了关注,文章的主要内容是关于发病率和死亡率的报告,研究显示,很大一部分诊断为艾滋病的儿童无法接受治疗。

关注:防儿童“成人慢性病”刻不容缓

第三届中国儿童肥胖和高血压学术会议近日在京召开。会议透露,1985年~2014年,我国7岁~18岁学龄儿童超重及肥胖率呈不断上升趋势,从2.6%增长到19.4%;儿童高血压患病率从1991年的7.1%上升到2009年的13.8%。与会专家表示,面对庞大的儿童肥胖人群以及过早于儿童期发生的高血压、糖脂代谢异常、非酒精性脂肪肝、骨密度不足等“成人病”的上升趋势,从儿童期防控“成人慢性病”已刻不容缓。

Diabetes Care:儿童期1型糖尿病发展至终末期肾病现状!

终末期肾病(ESRD)是1型糖尿病最严重并发症之一。近期,一项发表在杂志Diabetes Care上的研究旨在估计儿童期发病1型糖尿病患者随后长达42年的ESRD累积发病率。此项研究的数据是基于挪威全国童年糖尿病登记处,包括1973-1982年和1989-2012年期间接受诊断的新发1型糖尿病(年龄<15岁)的患者。后续研究到ESRD、死亡、移民或2015年11月30日为止。研究者们通过与挪

儿童慢性咳嗽怎么治效果好

在儿科门诊,以咳嗽为主诉就诊的患儿可占到门诊量的50%以上,而常用的治疗方法又似乎难以奏效,有些孩子会因为咳嗽症状反复迁延,严重影响他们的正常生活与学习。因此,慢性咳嗽一直是一线临床医生关注的诊断难点。那么,遇到慢性咳嗽的儿童,诊治中有哪些需要格外关注的呢?

Lancet Psychiatry:过早入学增加儿童注意缺陷多动障碍风险

研究认为,入学年龄越早的儿童其注意缺陷多动障碍风险增加,且该趋势在近年来尤为显著,该现象需受到全社会以及各个学龄儿童家庭的重视

JACC:伊伐布雷定在扩张型心肌病和症状性慢性心衰儿童中有何作用?

2017年9月,发表在《J Am Coll Cardiol》上的一项12个月、随机、双盲、安慰剂对照、2/3期研究,研究了伊伐布雷定在扩张型心肌病和症状性慢性心衰儿童中的作用。研究结果表明:伊伐布雷定可安全降低慢性心衰和扩张型心肌病儿童的静息心率。且对心率的影响具有差异,强调了调整剂量的重要性。此外伊伐布雷定可改善左心室射血分数,在临床状态和生活质量都表现出了有利的趋势。